PPP4R1L expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.944400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.212000E-01
Normal-vs-Stage2
9.654800E-01
Normal-vs-Stage3
7.768800E-01
Normal-vs-Stage4
7.841200E-01
Stage1-vs-Stage2
1.796570E-01
Stage1-vs-Stage3
2.490200E-01
Stage1-vs-Stage4
4.784800E-01
Stage2-vs-Stage3
6.424800E-01
Stage2-vs-Stage4
6.916200E-01
Stage3-vs-Stage4
6.265800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.189400E-01
Normal-vs-AfricanAmerican
2.533800E-01
Normal-vs-Asian
6.644800E-01
Caucasian-vs-AfricanAmerican
3.112400E-01
Caucasian-vs-Asian
5.600000E-01
AfricanAmerican-vs-Asian
5.613200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.483400E-01
Normal-vs-Female
6.868600E-01
Male-vs-Female
9.507700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.014600E-01
Normal-vs-Age(41-60Yrs)
9.339600E-01
Normal-vs-Age(61-80Yrs)
8.360000E-01
Normal-vs-Age(81-100Yrs)
7.849000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.591400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.928600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.145400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.051000E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.266600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.539400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.804600E-01
Normal-vs-Daily Drinker
8.281200E-01
Normal-vs-Weekly Drinker
7.150600E-01
Normal-vs-Occasional Drinker
9.656600E-01
Normal-vs-Social Drinker
7.093600E-01
Non Drinker-vs-Daily Drinker
3.052400E-01
Non Drinker-vs-Weekly Drinker
8.499800E-01
Non Drinker-vs-Occasional Drinker
6.239800E-01
Non Drinker-vs-Social Drinker
8.011800E-01
Daily Drinker-vs-Weekly Drinker
3.525200E-01
Daily Drinker-vs-Occasional Drinker
5.927200E-01
Daily Drinker-vs-Social Drinker
3.256800E-01
Weekly Drinker-vs-Occasional Drinker
5.505600E-01
Weekly Drinker-vs-Social Drinker
9.579000E-01
Occasional Drinker-vs-Social Drinker
5.198600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.604400E-01
Normal-vs-Grade 2
1.274220E-01
Normal-vs-Grade 3
6.149900E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.119660E-02
Grade 1-vs-Grade 3
1.402070E-03
Grade 1-vs-Grade 4
3.604400E-01
Grade 2-vs-Grade 3
3.274000E-01
Grade 2-vs-Grade 4
1.274220E-01
Grade 3-vs-Grade 4
6.149900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.320600E-01
Normal-vs-NonDiabetic
8.936600E-01
Diabetic-vs-NonDiabetic
9.114000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.667600E-01
Normal-vs-NoPancreatitis
8.370000E-01
Pancreatitis-vs-NoPancreatitis
2.020800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.169400E-01
Normal-vs-N1
9.941000E-01
N0-vs-N1
2.045600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.595200E-01
Normal-vs-TP53-NonMutant
3.686800E-01
TP53-Mutant-vs-TP53-NonMutant
1.87829999998002E-06
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
